Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 1
1990 1
1998 1
2003 1
2005 1
2007 1
2011 1
2013 1
2014 1
2015 1
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A, Domont J, Cioffi A, Le Cesne A. Patrikidou A, et al. Curr Treat Options Oncol. 2011 Mar;12(1):21-31. doi: 10.1007/s11864-011-0145-5. Curr Treat Options Oncol. 2011. PMID: 21384115 Review.
With the exception of male, older than 40 years, with a non-optimal resection of their primary (R1 resection) or in the subgroup of grade 3 STS, no other relevant clinical prognostic/predictive factors have been highlighted. The take home messages in 2011 could be a …
With the exception of male, older than 40 years, with a non-optimal resection of their primary (R1 resection) or in the subgroup of grade 3 …
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Kobus M, Roohani S, Ehret F, Flörcken A, Striefler JK, Brandes F, Märdian S, Rau D, Wittenberg S, Öllinger R, Kaul D. Kobus M, et al. Radiat Oncol. 2022 Aug 8;17(1):139. doi: 10.1186/s13014-022-02106-2. Radiat Oncol. 2022. PMID: 35941656 Free PMC article.
Twenty-three patients (20.0%) were treated with neoadjuvant RCT, 92 (80.0%) received other therapies (adjuvant RT alone (n = 58); neoadjuvant CTX + adjuvant RT (n = 17); adjuvant RCT (n = 10), neoadjuvant RT alone (n = 7)). To assess potential prognostic factors on LC, OS, …
Twenty-three patients (20.0%) were treated with neoadjuvant RCT, 92 (80.0%) received other therapies (adjuvant RT alone (n = 58); neoadjuvan …
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort).
Derbel O, Heudel PE, Cropet C, Meeus P, Vaz G, Biron P, Cassier P, Decouvelaere AV, Ranchere-Vince D, Collard O, De Laroche E, Thiesse P, Farsi F, Cellier D, Gilly FN, Blay JY, Ray-Coquard I. Derbel O, et al. PLoS One. 2017 Feb 3;12(2):e0158406. doi: 10.1371/journal.pone.0158406. eCollection 2017. PLoS One. 2017. PMID: 28158190 Free PMC article.
Adherence to CPGs for surgery was the strongest independent prognostic factor of PFS, along with age, gender, grade, and tumor size. For OS, multivariate analysis adherence to CPGs for surgery was a strong independent prognostic factor, with an important interaction …
Adherence to CPGs for surgery was the strongest independent prognostic factor of PFS, along with age, gender, grade, and tumor size. …
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.
Huang X, Park H, Greene J, Pao J, Mulvey E, Zhou SX, Albert CM, Moy F, Sachdev D, Yee D, Rader C, Hamby CV, Loeb DM, Cairo MS, Zhou X. Huang X, et al. PLoS One. 2015 Jul 14;10(7):e0133152. doi: 10.1371/journal.pone.0133152. eCollection 2015. PLoS One. 2015. PMID: 26173023 Free PMC article.
Patients with metastatic or recurrent and refractory sarcomas have a dismal prognosis. Therefore, new targeted therapies are urgently needed. This study was designed to evaluate chimeric antigen receptor (CAR) T cells targeting the type I insulin-like growth factor recepto …
Patients with metastatic or recurrent and refractory sarcomas have a dismal prognosis. Therefore, new targeted therapies are urgently …
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. Zagars GK, et al. Cancer. 2003 May 15;97(10):2530-43. doi: 10.1002/cncr.11365. Cancer. 2003. PMID: 12733153 Free article.
BACKGROUND: Prognostic factors for patients with soft-tissue sarcoma who are treated with conservative surgery and radiation are documented poorly. ...Actuarial univariate and multivariate statistical methods were used to determine significant prognostic factors for …
BACKGROUND: Prognostic factors for patients with soft-tissue sarcoma who are treated with conservative surgery and radiation are docu …
Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
Erzen D, Sencar M, Novak J. Erzen D, et al. J Surg Oncol. 2005 Jul 1;91(1):1-9. doi: 10.1002/jso.20265. J Surg Oncol. 2005. PMID: 15999353
BACKGROUND AND OBJECTIVES: Retroperitoneal sarcomas are rare malignant tumors with an aggressive course of disease and high local recurrence rate. Local disease is the main cause of death. ...
BACKGROUND AND OBJECTIVES: Retroperitoneal sarcomas are rare malignant tumors with an aggressive course of disease and high local rec …
Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region.
Heudel PE, Cousin P, Lurkin A, Cropet C, Ducimetiere F, Collard O, De Laroche G, Biron P, Meeus P, Thiesse P, Bergeron C, Vaz G, Mithieux F, Farsi F, Fayet Y, Gilly FN, Cellier D, Blay JY, Ray-Coquard I. Heudel PE, et al. Int J Clin Oncol. 2014 Aug;19(4):744-52. doi: 10.1007/s10147-013-0601-2. Epub 2013 Aug 10. Int J Clin Oncol. 2014. PMID: 23933822
METHODS: From March 2005 to February 2007, all patients diagnosed with localized sarcoma in the Rhone-Alpes region were included in a cohort-based study, to evaluate the compliance of sarcoma management with French guidelines in routine practice and to identify predictive …
METHODS: From March 2005 to February 2007, all patients diagnosed with localized sarcoma in the Rhone-Alpes region were included in a cohort …
Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II.
Raney RB Jr, Gehan EA, Hays DM, Tefft M, Newton WA Jr, Haeberlen V, Maurer HM. Raney RB Jr, et al. Cancer. 1990 Nov 15;66(10):2072-81. doi: 10.1002/1097-0142(19901115)66:10<2072::aid-cncr2820661006>3.0.co;2-9. Cancer. 1990. PMID: 2224761 Clinical Trial.
After incisional biopsy, 109 patients with localized, gross residual sarcoma of the prostate (43 patients), bladder (43 patients), vagina (20 patients), or cervix/uterine corpus (3 patients) were treated with vincristine, dactinomycin, and cyclophosphamide (VAC). After two to fou …
After incisional biopsy, 109 patients with localized, gross residual sarcoma of the prostate (43 patients), bladder (43 patients), vagina (2 …
Aggressive surgical treatment of retroperitoneal sarcoma: long-term experience of a single institution.
Erzen D, Novak J, Spiler M, Sencar M. Erzen D, et al. Surg Technol Int. 2007;16:97-106. Surg Technol Int. 2007. PMID: 17429776
When only R0 resection was considered, referral status (primary, residual, recurrent RSTS) influenced survival (p = 0.004). The quality of initial surgery is a crucial prognostic factor to predicting survival in patients with RSTS. Complete surgical resection withou …
When only R0 resection was considered, referral status (primary, residual, recurrent RSTS) influenced survival (p = 0.004). The quality of i …
12 results